In a recent study, Kouzi et al. delineate a higher expression of Cx25, Cx31.9, and Cx59 in AML blasts and BM CD34+ cells, while the differential expression of these connexins was independent of the cytogenetic or molecular status of AML cells. The gene discussed is GJD3; the disease is acute myeloid leukemia.